Tumor-infiltrating lymphocytes (TILs) in the HCC encompass the group of diverse immune cells such as CD8+ T cells, CD4+ T cells, Tregs, NK cells, or B cells that affect HCC progression through compound immunological mechanisms and interactions with various cells and TME [99]. This evidence concerns the gene CD8A and neoplasm.